Nephrx
Latest round
- Series B
Last raised
- Mar 2002
Total raised
- $0.8M
Investors
- 2
About Nephrx
NephRx is a biotechnology company dedicated to the discovery and development of therapeutic products for the treatment of acute kidney failure/disease and diseases of the gastrointestinal tract including mucositis.
Who invested in Nephrx
2 investors across 1 round
See all investors in Nephrx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 1, 2002
Amount
$0.8M
Investors
Questions about Nephrx
Who invested in Nephrx?
Nephrx has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nephrx raised?
Nephrx has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nephrx last raise money?
Nephrx's most recent round on record is a Series B, in Mar 2002.
What does Nephrx do?
NephRx is a biotechnology company dedicated to the discovery and development of therapeutic products for the treatment of acute kidney failure/disease and diseases of the gastrointestinal tract including mucositis.
Where is Nephrx headquartered?
Nephrx is headquartered in Kalamazoo, US.
Which VCs invest in companies like Nephrx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nephrx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Nephrx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.